About Harrington discovery institute at university hospitals
The Harrington Discovery Institute at University Hospitals: Accelerating Promising Discoveries into Medicines for Unmet Needs
The Harrington Discovery Institute at University Hospitals is a non-profit organization that aims to accelerate promising discoveries into medicines for unmet needs. The institute was founded in 2012 by Dr. Jonathan Stamler, a renowned physician-scientist and inventor of several drugs, with the vision of bridging the gap between academic research and drug development.
The institute is named after Ron Harrington, a successful entrepreneur who donated $50 million to support its mission. The institute's headquarters are located in Cleveland, Ohio, but it collaborates with researchers from all over the world.
The Harrington Discovery Institute offers several programs to support drug discovery and development. One of its flagship programs is the Harrington Scholar-Innovator Award, which provides funding and mentorship to physician-scientists who have promising ideas for new drugs but lack the resources or expertise to develop them.
Another program is the Innovation Support Center (ISC), which provides consulting services on drug discovery and development to academic researchers and small biotech companies. The ISC has a team of experts in medicinal chemistry, pharmacology, toxicology, intellectual property law, regulatory affairs, and business development.
In addition to these programs, the Harrington Discovery Institute also hosts an annual symposium on innovation in drug discovery and development. The symposium brings together leading scientists from academia and industry to discuss cutting-edge research topics such as precision medicine, gene therapy, immunotherapy, and artificial intelligence.
One of the unique features of the Harrington Discovery Institute is its focus on translational research – that is research that aims to translate basic scientific discoveries into clinical applications. This approach requires close collaboration between basic scientists who discover new targets or pathways relevant for disease treatment or prevention; medicinal chemists who design molecules that can modulate these targets; pharmacologists who test these molecules in cells or animal models; toxicologists who assess their safety profile; clinicians who conduct clinical trials with patients; regulatory experts who navigate FDA approval process; investors who provide funding for commercialization; patient advocates who ensure patient-centricity throughout this process.
To facilitate this collaborative approach towards translational research across different disciplines requires not only scientific expertise but also effective communication skills among team members with diverse backgrounds. Therefore another unique feature of HDI’s approach towards translational science involves training young investigators not only on scientific aspects but also leadership skills such as teamwork building , conflict resolution , project management etc .
Overall HDI’s mission aligns well with current trends towards personalized medicine where treatments are tailored based on individual genetic makeup rather than one-size-fits-all approaches . By accelerating promising discoveries into medicines for unmet needs , HDI hopes not only improve health outcomes but also create economic value by bringing innovative therapies from bench-to-bedside thereby creating jobs & improving quality-of-life .
In conclusion , if you are looking for an organization dedicated towards accelerating innovative therapies from bench-to-bedside then look no further than “Harrington discovery institute at university hospitals”. With its unique focus on translational science & collaborative approach across different disciplines along-with strong leadership training program makes it an ideal place for young investigators looking make difference in healthcare sector while advancing their careers .
harringtondiscovery.org
